XML 59 R44.htm IDEA: XBRL DOCUMENT v3.26.3
Stockholders' Equity (Tables)
 12 Months Ended
Aug. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Recognized Stock-Based Compensation
The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):
Fiscal Year Ended August 31,
202620252024
Restricted stock units$117 $89 $70 
Employee stock purchase plan23 18 19 
Total$140 $107 $89 
Schedule of Shares Available for Issuance
Following is a reconciliation of the shares of common stock available to be issued under the 2021 EIP as of August 31, 2026:
Shares Available for Grant
Balance as of August 31, 2025
7,135,170 
Restricted stock units granted, net of forfeitures(1)
(542,142)
Balance as of August 31, 2026
6,593,028 
 
(1)Represents the maximum number of shares of common stock that can be issued based on the achievement of certain performance criteria.
Schedule of Restricted Stock Activity
The following table summarizes restricted stock units activity from August 31, 2025 through August 31, 2026:
SharesWeighted-Average
Grant-Date
Fair Value
Outstanding as of August 31, 2025
2,317,754 $115.06 
Changes during the period
Shares granted(1)
637,500 $224.12 
Shares vested(1,121,753)$87.81 
Shares forfeited(95,358)$123.28 
Outstanding as of August 31, 2026
1,738,143 $172.20 
(1)For those shares of common stock granted that are based on the achievement of certain performance criteria, the amount represents the maximum number of shares of common stock that can vest. During the fiscal year ended August 31, 2026, the Company awarded approximately 0.4 million time-based restricted stock units, 0.1 million performance-based restricted stock units and 0.1 million market-based restricted stock units based on target performance criteria.
Schedule of Share-Based Compensation Information
The following table represents the restricted stock units stock-based compensation information for the periods indicated (in millions):
Fiscal Year Ended August 31,
202620252024
Fair value of restricted stock units vested$99 $91 $85 
Tax benefit for stock compensation expense(1)
$4 $2 $3 
Unrecognized stock-based compensation expense – restricted stock units$63 
Remaining weighted-average period for restricted stock units expense1.3 years
 
(1)Classified as income tax expense within the Consolidated Statements of Operations.
Schedule of Weighted Average Assumptions Used in Black-Scholes Option Pricing Model
The fair value of shares of common stock issued under the ESPP was estimated on the commencement date of each offering period using the Black-Scholes option pricing model. The following weighted-average assumptions were used in the model for each respective period:
Fiscal Year Ended August 31,
202620252024
Expected dividend yield0.1 %0.1 %0.1 %
Risk-free interest rate4.0 %4.9 %5.4 %
Expected volatility(1)
40.6 %39.1 %34.1 %
Expected life0.5 years0.5 years0.5 years
(1)The expected volatility was estimated using the historical volatility derived from the Company’s common stock.
Schedule of Cash Dividends Declared to Common Stockholders
The following table sets forth certain information relating to the Company’s cash dividends declared to common stockholders during fiscal years 2026 and 2025:
(in millions, except for per share data)Dividend
Declaration Date		Dividend
per Share		Total of Cash
Dividends
Declared		Date of Record for
Dividend Payment		Dividend Cash
Payment Date
Fiscal Year 2026
October 16, 2025$0.08 $9 November 17, 2025December 2, 2025
January 22, 2026$0.08 $9 February 17, 2026March 3, 2026
April 23, 2026$0.08 $8 May 15, 2026June 2, 2026
July 16, 2026$0.08 $8 August 14, 2026September 2, 2026
Fiscal Year 2025
October 17, 2024$0.08 $9 November 15, 2024December 3, 2024
January 23, 2025$0.08 $8 February 18, 2025March 4, 2025
April 16, 2025$0.08 $9 May 15, 2025June 3, 2025
July 17, 2025$0.08 $9 August 15, 2025September 3, 2025
Schedule of Common Stock Outstanding
The following represents the common stock outstanding for the fiscal year ended:
Fiscal Year Ended August 31,
202620252024
Common stock outstanding:
Beginning balances
107,480,895 113,744,167 131,294,422 
Shares issued under employee stock purchase plan
383,194 593,727 628,960 
Vesting of restricted stock
1,121,753 1,117,182 1,802,380 
Purchases of treasury stock under employee stock plans
(319,406)(330,256)(537,318)
Treasury shares purchased(4,190,651)(7,643,925)(19,444,277)
Ending balances
104,475,785 107,480,895 113,744,167 
Schedule of Repurchase of Common Stock under Share Repurchase Program and Common Stock Repurchased through Open Market
The Company repurchases shares of its common stock under share repurchase programs authorized by the Company’s Board of Directors. The following Board approved share repurchase programs were executed through a combination of accelerated share repurchase (“ASR”) agreements and open market transactions (in millions):
Board Approval DateAmount AuthorizedShares RepurchasedTotal Cash UtilizedRemaining AuthorizationAuthorization Completion Date
Amended 2023 Share Repurchase ProgramQ1 FY 2024$2,500 20.4$2,500 $— Q1 FY 2025
2025 Share Repurchase ProgramQ1 FY 2025$1,000 6.6$1,000 $— Q4 FY 2025
2026 Share Repurchase ProgramQ4 FY 2025$1,000 4.0$1,000 $— Q4 FY 2026
2027 Share Repurchase Program(1)
Q4 FY 2026$1,500 1.9$602 $898 
(1)As of August 31, 2026, 0.2 million shares of common stock had been repurchased for $60 million and $1.4 billion remains available under the 2027 Share Repurchase Program. As of October 20, 2026, 1.9 million shares of common stock had been repurchased for $602 million and $898 million remained available under the 2027 Share Repurchase Program.
In addition, the Company repurchased shares of its common stock through the open market as follows (in millions):
Fiscal Year Ended August 31,
202620252024
SharesCostSharesCostSharesCost
Open market share repurchases(1)
3.2$815 2.8$377 11.3$1,445 
(1)As of October 20, 2026, 1.1 million shares of common stock had been repurchased for $321 million through open market transactions under the 2027 Share Repurchase Program.
Schedule of Accelerated Share Repurchases Agreement
The terms of ASR agreements, structured as outlined above, were as follows (in millions, except average price):
Agreement Execution DateAgreement Settlement DateAgreement AmountInitial Shares DeliveredAdditional Shares DeliveredTotal Shares DeliveredAverage Price Paid Per Share
Q1 FY 2024Q1 FY 2024$500 3.30.63.9$128.61 
Q4 FY 2024Q1 FY 2025$555 4.21.05.2$107.08 
Q2 FY 2025Q3 FY 2025$310 1.80.22.0$154.44 
Q3 FY 2025Q4 FY 2025$309 1.80.01.8$171.91 
Q1 FY 2026Q2 FY 2026(1)$45 0.20.00.2$209.67 
Q2 FY 2026Q3 FY 2026(2)$200 0.80.00.8$246.29 
Q1 FY 2027Q2 FY 2027$281 0.8(3)(3)$304.41 
(1)In October 2025, the Company entered into ASR agreements to repurchase $45 million, excluding excise tax, of the Company’s common stock. Under the ASR agreements, the Company made payments of $45 million to participating financial institutions and received an initial delivery of shares of common stock. In December 2025, the ASR transaction was completed and the final delivery of shares of common stock was received.
(2)In December 2025, the Company entered into ASR agreements to repurchase $200 million, excluding excise tax, of the Company’s common stock. Under the ASR agreements, the Company made payments of $200 million to participating financial institutions and received an initial delivery of shares of common stock. In March 2026, the ASR transaction was completed and the final delivery of shares of common stock was received.
(3)In October 2026, the Company entered into ASR agreements to repurchase $281 million, excluding excise tax, of the Company’s common stock. Under the ASR agreements, the Company made payments of $281 million to participating financial institutions and received an initial delivery of shares of common stock. The delivery of any remaining shares of common stock will occur at the final settlement of the transactions under the ASR agreements.
Schedule of Estimated Fair Value of Warrant
The estimated fair value of the Warrant was determined as of the issuance date, using the Black-Scholes option pricing model. The following assumptions were used in the model:
December 27, 2024
Stock price$145.92
Exercise price$137.77
Expected life7.0 years
Expected volatility(1)
34.4 %
Risk-free interest rate4.5 %
(1)The expected volatility was estimated using the historical volatility derived from the Company’s common stock.